China (Mainland)
Premiumsupplier
- Product Details
Keywords
- Lenvatinib
- Lenvatinib manufacturer
- High-quality E7080
Quick Details
- ProName: Lenvatinib(CAS417716-92-8)
- CasNo: 417716-92-8
- Molecular Formula: C21H19ClN4O4
- Appearance: white powder
- Application: E7080 (Lenvatinib) is a multi-target i...
- DeliveryTime: Within7-10 days after receipt of your ...
- PackAge: As customer request
- Port: Qingdao,China
- ProductionCapacity: 100 Kilogram/Week
- Purity: 99%
- Transportation: By Sea/Air/Courier
- LimitNum: 10 Gram
Superiority
Lorcaserin(856681-05-5)is an orally administered agent and a selective 5-HT2C receptor agonist for the treatment of obesity. It had been approved for marketing in US by FDA on 27 June in 2012. In clinical studies, lorcaserin has demonstrated efficacy in obese and overweight populations by promoting weight loss and improving metabolic parameters, and it is well tolerated.
Details
Lenvatinib
| CAS: | 417716-92-8 |
| MF: | C21H19ClN4O4 |
| MW: | 426.85 |
| Appearance: | White powder |
| Assay: | 99% |
| Boiling point: | 627.2±55.0 °C(Predicted) |
| desnity: | 1.46 |
| Uses: |
Lenvatinib is a thyroid cancer drug. E7080 (Lenvatinib) is a multi-target inhibitor of VEGFR2 and VEGFR3 with IC50 of 4 nM and 5.2 nM, respectively. |
